Prelude Therapeutics Inc 10-K for FY2022
Prelude Therapeutics Inc (PRLD)
10-K
2023-03-15
For: 2022-12-31
View Original
Added on
April 06, 2026
About this 10-K
Prelude Therapeutics Inc filed this 10-K on March 15, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $115.44M
- compared with a net loss of $111.69M a year earlier
- Diluted EPS
- -$2.44
- compared with -$2.43 a year earlier